Kenneth R. Lynn

U.S. Bioscience, Inc. is a pharmaceutical company specializing in the development and commercialization of products for patients with cancer and AIDS and allied infections. The company has three products on the market. In addition to its headquarters, U.S. Bioscience has a manufacturing facility located in Nijmegen, The Netherlands, an analytical laboratory in Exton, PA, and a subsidiary near London to coordinate clinical trials in Europe. U.S. Bioscience, Inc. is headquartered in West Conshohocken, PA.

U.S. Bioscience, Inc. is a pharmaceutical company specializing in the development and commercialization of products for patients with cancer and AIDS and allied infections. The company has three products on the market. In addition to its headquarters, U.S. Bioscience has a manufacturing facility located in Nijmegen, The Netherlands, an analytical laboratory in Exton, PA, and a subsidiary near London to coordinate clinical trials in Europe. U.S. Bioscience, Inc. is headquartered in West Conshohocken, PA.

Founded in 1987, the Kansas Technology Enterprise Corporation is a private/public partnership established by the state of Kansas to promote technology based economic development. They are located in Topeka, Kansas

RxKinetix, Inc. develops new therapeutic drugs. The company uses proven pharmaceuticals and proprietary polymer-based drug delivery technologies and creates new drugs or enhances existing drugs. It also develops drugs for oral mucositis and other supportive care oncology conditions. RxKinetix was founded in 1996 and is located in Boulder, CO

RxKinetix, Inc. develops new therapeutic drugs. The company uses proven pharmaceuticals and proprietary polymer-based drug delivery technologies and creates new drugs or enhances existing drugs. It also develops drugs for oral mucositis and other supportive care oncology conditions. RxKinetix was founded in 1996 and is located in Boulder, CO

Founded in 1987, the Kansas Technology Enterprise Corporation is a private/public partnership established by the state of Kansas to promote technology based economic development. They are located in Topeka, Kansas

Founded in 1987, the Kansas Technology Enterprise Corporation is a private/public partnership established by the state of Kansas to promote technology based economic development. They are located in Topeka, Kansas

Founded in 1987, the Kansas Technology Enterprise Corporation is a private/public partnership established by the state of Kansas to promote technology based economic development. They are located in Topeka, Kansas

Founded in 1987, the Kansas Technology Enterprise Corporation is a private/public partnership established by the state of Kansas to promote technology based economic development. They are located in Topeka, Kansas

Founded in 1987, the Kansas Technology Enterprise Corporation is a private/public partnership established by the state of Kansas to promote technology based economic development. They are located in Topeka, Kansas

U.S. Bioscience, Inc. is a pharmaceutical company specializing in the development and commercialization of products for patients with cancer and AIDS and allied infections. The company has three products on the market. In addition to its headquarters, U.S. Bioscience has a manufacturing facility located in Nijmegen, The Netherlands, an analytical laboratory in Exton, PA, and a subsidiary near London to coordinate clinical trials in Europe. U.S. Bioscience, Inc. is headquartered in West Conshohocken, PA.

Founded in 1987, the Kansas Technology Enterprise Corporation is a private/public partnership established by the state of Kansas to promote technology based economic development. They are located in Topeka, Kansas

Founded in 1987, the Kansas Technology Enterprise Corporation is a private/public partnership established by the state of Kansas to promote technology based economic development. They are located in Topeka, Kansas

Founded in 1987, the Kansas Technology Enterprise Corporation is a private/public partnership established by the state of Kansas to promote technology based economic development. They are located in Topeka, Kansas

Valentis lead drug candidate, Deltavasc, may treat peripheral arterial and ischemic heart disease with a gene that spurs new blood vessels to form (a process known as angiogenesis). In early stages of development are DNA vaccines for HIV, hepatitis C, and other viral infections. Another drug candidate, eNOS, could prevent tissue rejection in transplant recipients. The company licenses its technology -- include the GeneSwitch platform, which can turn off or on gene therapies -- to other drugmakers. These licensees include Genzyme, Pfizer, and GlaxoSmithKline.